Shineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor Patients
24 févr. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical Devices
17 févr. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Enters Into Cooperation Agreement to Jointly Manufacture PET and Explore High-end Medical Imaging Devices Field
03 févr. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant
01 févr. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Enters Into Share Transfer Agreements to Acquire 51% Equity Interest in Xiang Peng You Kang (Beijing) Technology Co., Ltd.
18 janv. 2022 09h00 HE
|
Shineco, Inc.
BEIJING, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD
06 déc. 2021 16h15 HE
|
Shineco, Inc.
BEIJING, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Intends to Acquire a Controlling Interest of Xiang Peng You Kang (Beijing) Technology Co., Ltd., a Healthcare Services Company
03 déc. 2021 09h00 HE
|
Shineco, Inc.
As a Preemptive Action to Develop Comprehensive Medical and Healthcare Services BEIJING, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and...
Shineco, Inc. Explores Medical Aesthetic Industry by Entering into MOU with Dragon Pride Limited
26 oct. 2021 09h00 HE
|
Shineco, Inc.
BEIJING, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Shineco, Inc. Announces Nasdaq Ticker Symbol Change from "TYHT" to "SISI"
15 oct. 2021 09h00 HE
|
Shineco, Inc.
BEIJING, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products...
Shineco, Inc. Intends to Acquire Biotechnology Company to Jointly Develop Rapid-acting Antidepressant Natural Innovative Medicine
05 oct. 2021 08h00 HE
|
Shineco, Inc.
BEIJING, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products...